Co-Diagnostics, Inc. Common Stock (CODX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.72M
Last updated: Nov 17, 2026 at 11:03 AM ET
Co-Diagnostics, Inc. Common Stock (CODX) Stock Forecast
Analysts expect Co-Diagnostics, Inc. Common Stock (CODX) to earn -$3.10 per share in the fiscal year ending Dec 31, 2026, on revenue of $654000. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.83.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 2546.8%.
- Fiscal year ending Dec 31, 2026
- -$3.10
- EPS consensus, revenue $654000
- Fiscal year ending Dec 31, 2027
- -$0.83
- EPS consensus, revenue $17.31M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.10 | -$3.10 to -$3.10 | 1 | $654000 | $654000 to $654000 | 1 |
| Dec 31, 2027 | -$0.83 | -$0.83 to -$0.83 | 1 | $17.31M | $17.31M to $17.31M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.28 | N/A | 3 | $176460 | $169540 to $181650 | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$12.15.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.10 | -$13.50 | -$13.50 | -$13.50 | -$12.15 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.83 | -$12.00 | -$12.00 | -$12.00 | -$12.00 | N/A |
Frequently Asked Questions About CODX
What is the CODX stock forecast?
Consensus analyst estimates put Co-Diagnostics, Inc. Common Stock's EPS at -$3.10 for the fiscal year ending Dec 31, 2026, on revenue of $654000.
What EPS do analysts expect from CODX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.10, with estimates from -$3.10 to -$3.10 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.83, with estimates from -$0.83 to -$0.83 from 1 analyst.
What revenue do analysts expect from Co-Diagnostics, Inc. Common Stock next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $654000, with estimates from $654000 to $654000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $17.31M, with estimates from $17.31M to $17.31M.
How many analysts cover CODX?
1 analyst estimates EPS for Co-Diagnostics, Inc. Common Stock for the fiscal year ending Dec 31, 2026.
CODX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors